Valuation: Sartorius AG

Market Cap 17.83B 19.94B 16.5B 14.94B 27.95B 1,897B 28.41B 199B 78.52B 992B 74.84B 73.24B 3,142B P/E 2026 *
73.2x
P/E 2027 * 57.4x
Enterprise Value 21.41B 23.94B 19.81B 17.93B 33.56B 2,278B 34.11B 238B 94.28B 1,191B 89.85B 87.93B 3,772B EV / Sales 2026 *
5.74x
EV / Sales 2027 * 5.14x
Free-Float
35.87%
Yield 2026 *
0.27%
Yield 2027 * 0.33%
1 day+2.82%
1 week+5.80%
Current month+6.31%
1 month+6.31%
3 months+25.14%
6 months+33.54%
Current year+18.38%
1 week 40.4
Extreme 40.4
43.8
1 month 38.6
Extreme 38.6
43.8
Current year 31.6
Extreme 31.6
43.8
1 year 31.6
Extreme 31.6
43.8
3 years 29
Extreme 29
55
5 years 29
Extreme 29
110
10 years 29
Extreme 29
174
Manager TitleAgeSince
Chief Executive Officer 59 2025-06-29
Director of Finance/CFO 55 2024-03-31
Chief Operating Officer 70 2000-12-31
Director TitleAgeSince
Director/Board Member 62 2002-08-31
Chairman 69 2017-07-18
Director/Board Member 77 2011-11-28
Change 5-day change 1-year change 3-year change Capi.($)
+2.82%+5.80% - - 19.49B
+1.64%-0.74%+19.63%+58.11% 249B
+1.07%+1.72%+4.47%+20.93% 162B
-0.15%+5.84%-17.36%+69.40% 157B
-0.24%+2.68%-54.92%-8.82% 66.22B
-1.50%+2.52%+8.59%+63.35% 52.3B
+1.03%+2.03%-14.62%-11.58% 52.18B
+1.67%+4.57%+19.00%+32.51% 51.34B
+1.67%+1.73%+18.87%+70.17% 48.79B
+0.51%+4.36%+26.84%+88.19% 44.57B
Average +0.77%+2.12%+1.17%+42.47% 98.17B
Weighted average by Cap. +0.66%+1.40%+2.30%+45.16%

Financials

2026 *2027 *
Net sales 3.73B 4.17B 3.45B 3.12B 5.85B 397B 5.94B 41.53B 16.43B 208B 15.66B 15.32B 657B 4.11B 4.59B 3.8B 3.44B 6.44B 437B 6.54B 45.72B 18.08B 229B 17.24B 16.87B 724B
Net income 258M 288M 239M 216M 404M 27.44B 411M 2.87B 1.14B 14.35B 1.08B 1.06B 45.44B 333M 373M 308M 279M 523M 35.47B 531M 3.71B 1.47B 18.55B 1.4B 1.37B 58.74B
Net Debt 3.58B 4B 3.31B 3B 5.61B 381B 5.7B 39.83B 15.76B 199B 15.02B 14.7B 630B 3.27B 3.66B 3.03B 2.74B 5.13B 348B 5.21B 36.42B 14.41B 182B 13.73B 13.44B 576B
Projected Income Statement - Annual - Sartorius AG
Logo Sartorius AG
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Employees
14,273
Date Price Change
26-10-26 €43.80 +2.82%
26-10-23 €42.60 +2.90%
26-10-22 €41.40 -2.36%
26-10-21 €42.40 +4.95%
26-10-20 €40.40 0.00%
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Sartorius AG
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
19
Last Close Price
289.50EUR
Average target price
286.37EUR
Spread / Average Target
-1.08%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Sartorius AG